Press Release: DMC Demonstrates Full Commercial Scale At Record Speed
- Details
- Monday, 15 March 2021
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the performance at bench and pilot scales, further validating the predictability and scalability of DMC’s Dynamic Metabolic Control technology. Importantly, commercial performance metrics were demonstrated, meaning that no further strain improvements are required to achieve the target selling price.
LUXEMBOURG - 9 March 2021 - Luxembourg-based company Capsul’in Pro has today launched its Zero Impact Nespresso®-compatible coffee capsule, the first of its kind to be 100% biobased, certified home compostable and with a high oxygen barrier that protects the flavour and aroma of the coffee. The Zero Impact capsule is completely plant-based and does not contain materials derived from fossil fuels. After use, the capsule can be put in a home compost bin or collected with organic waste. 
OSLO, NORWAY – 2 March 2021 – Biochemicals company Circa Group AS has successfully completed a private placement of 575 Norwegian Kroner (NOK) – approximately €56 million – in a transaction led by Pareto Securities and Sparebank 1 Markets in Oslo, at a post-money market valuation of approximately NOK 2 billion (approximately €194 million). The company (ticker code: CIRCA) shares starts trading on Euronext Growth Oslo at 09:00 CET today (2 March 2021).
Sustainability Consult’s CEO Kathryn Sheridan spoke about credible communications and the opportunity for communicators to contribute to real change at the 11th edition of the EU Committee of the Regions communications conference EuroPCom in December 2020.
